Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
STMicroelectronics shares down 14% amid mixed future outlook📉
Stock of the Week - Merck & Co Inc (23.10.2025)
Beyond Meat after the sell-off📉Is short squeeze still possible?
Banco Macro gains 5% amid US Treasury help to Argentine peso 🗽